This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Bausch Health (BHC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed the most recent trading day at $18.85, moving -0.84% from the previous trading session.
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure
by Indrajit Bandyopadhyay
The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.
Bausch Health (BHC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed at $21.48 in the latest trading session, marking a -0.88% move from the prior day.
Aerie (AERI) Expands Market Presence Despite Stiff Competition
by Zacks Equity Research
Aerie (AERI) is progressing well with the development of its ophthalmology pipeline. Its partnership with Santen Pharmaceuticals allows it to expand the presence of its drugs outside the United States.
Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Bausch Health (BHC) closed at $23.23, marking a -1.69% move from the previous day.
Bausch Health (BHC) Stock Moves -0.56%: What You Should Know
by Zacks Equity Research
In the latest trading session, Bausch Health (BHC) closed at $23.17, marking a -0.56% move from the previous day.
Bausch (BHC) Up 1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bausch Health (BHC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed the most recent trading day at $24.05, moving +1.69% from the previous trading session.
Bausch Health (BHC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Bausch Health (BHC) closed at $21.97, marking a -1.08% move from the previous day.
Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed at $22.56 in the latest trading session, marking a -0.84% move from the prior day.
Bausch's (BHC) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Bausch (BHC) beats on earnings but misses on sales in the fourth quarter. The outlook for 2022 is disappointing.
Bausch Health (BHC) Beats Q4 Earnings Estimates
by Zacks Equity Research
Bausch (BHC) delivered earnings and revenue surprises of 17.59% and 0.45%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Drug/Biotech Stocks' Q4 Earnings on Feb 23: BMRN, BHC & More
by Zacks Equity Research
Let us take a look at five drug/biotech companies, namely, BMRN, CLVS, TBPH, BHC and GBT, which are due to release their quarterly results on Feb 23.
What's in the Cards for Bausch Health (BHC) Q4 Earnings?
by Zacks Equity Research
An update on the IPO of Bausch+Lomb and regular top-line and bottom-line numbers will grab investors' attention when BHC reports Q4 results.
Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed at $24.74 in the latest trading session, marking a -1.55% move from the prior day.
Bausch Health (BHC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed at $24.78 in the latest trading session, marking a +1.6% move from the prior day.
Bausch Health (BHC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Bausch Health (BHC) closed at $24.39 in the latest trading session, marking a -0.53% move from the prior day.
Bausch Health (BHC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Bausch Health (BHC) closed at $24.57, marking a +1.78% move from the previous day.
Should Value Investors Pick Bausch Health (BHC) Stock Now?
by Zacks Equity Research
Let's see if Bausch Health Companies Inc. (BHC) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Anthem's (ANTM) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q4 results reflect better revenues and a solid contribution from its Government Business and IngenioRx businesses, partly offset by escalating expenses.
Is a Beat in Store for HCA Healthcare's (HCA) Q4 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) fourth-quarter earnings are likely to have gained from rising admissions and higher revenues.
Will Bausch (BHC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Bausch (BHC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Bausch Health (BHC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Bausch Health (BHC) closed at $25.06, marking a +0.56% move from the previous day.
Anthem (ANTM) Gears Up for Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results are likely to reflect gains from increased premiums and strong membership growth across its Medicare and Medicaid businesses, partly offset by rising expenses.
UnitedHealth (UNH) Q4 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results reflect higher revenues, driven by segmental contributions, partly offset by steep expenses.